OROS [Off Topic]

posted by Jaime_R – Barcelona, 2010-12-29 16:30 (5656 d 14:55 ago) – Posting: # 6350
Views: 11,623

Dear Manan!

❝ Dear Jamie


Jaime, not Jamie. ;-)

❝ [...] However, as the cocept used here is osmotic pressure, i hope there will be some changes in the PK profile of the formulation.


Of course, that's the idea. For an example plasma profile see here.

❝ Do we have any guidline in place for OROS formaultion?

❝ can you please let me know in detail about the OROS formulation?


:google:!
What about this one?

❝ i searched FDA and EMEA guidances but i wasnt able to find it.


There are no specific guidelines. Why do you think there should be one? An osmotic pump is just a biopharmaceutical technology and therefore within the scope of modified release guidelines.

Regards, Jaime

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
113 visitors (0 registered, 113 guests [including 14 identified bots]).
Forum time: 08:25 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5